• Smoore International Holdings has begun a share repurchase program approved in May 2026. It allows buybacks of up to 619,559,572 shares, equal to 10% of its 6,195,595,725 issued shares, funded from legally available resources.
• The latest quarterly update showed CNY 3,946.2 million in sales and CNY 365.1 million in net income, with nine month figures of CNY 11,155.1 million in sales and CNY 937 million in net income, giving investors fresh insight into Smoore International Holdings' operating scale and profitability.
• Next, the focus turns to how Smoore International Holdings' new share repurchase program reshapes the existing investment narrative built around R&D led growth.

Spot potential buyback and earnings driven rerating stories beyond Smoore International Holdings by scanning our curated 615 high quality undiscovered gems in similar corners of the market.

Smoore International Holdings Investment Narrative Recap

Smoore International Holdings still hinges on a simple belief. You think vaping technology and adjacent atomization uses can keep scaling, while management holds margins together despite heavier R&D, marketing and regulatory friction. The latest quarterly figures show sales and net income in the billions of CNY, which keeps the operational story intact rather than transforming it.

In the near term, the key swing factor is whether customer concentration and policy risk around e-cigarettes stay manageable while new segments like beauty atomization and inhalation therapy mature. The fresh results do not remove those pressures. They do at least show the business generating profits that can support that investment push.

The share repurchase program approved in May 2026 and now active is the announcement that really matters in this context. It allows Smoore International Holdings to buy back up to 10% of its issued shares, with the board flagging potential improvement in net asset value per share and earnings per share if executed as planned.

For you, that sits alongside the existing catalysts. Execution on R&D heavy categories like Heat Not Burn and medical style atomization, adjustment to changing rules in the U.S. and Europe, and control of operating costs all remain central. The buyback adds an extra lever on per share metrics, while regulatory shifts and customer dependence still anchor risk.

Smoore International Holdings' analyst narrative points to forecast revenue of CN¥21.6b and expected earnings of CN¥2.3b by 2029, based on assumptions of 14.9% yearly revenue growth and an earnings increase of about CN¥1.2b from current earnings of CN¥1.1b.

Uncover why Smoore International Holdings' fair value indicates a 51% potential upside to its current price, which could narrow quickly.

Exploring Other Perspectives

One big swing factor that bullish analysts focus on is operating leverage. Before this buyback and earnings news, the most optimistic forecasts already pencilled in revenue of about CN¥26.4b and earnings of roughly CN¥3.2b by 2029. That is far above the baseline. You can treat today’s repurchases as a fresh data point that may push those narratives to reset in either direction, and it is worth comparing several viewpoints before deciding how you feel about Smoore International Holdings.

Explore 2 other Smoore International Holdings fair value estimates, including one that suggests as much as 332548% upside from the current price!

Form Your Own Verdict

Don't just follow the ticker, dig into the data and build a conviction that's truly your own.

• A great starting point for your Smoore International Holdings research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.
• See our latest analysis for Smoore International Holdings. The report includes a comprehensive fundamental analysis summarized in a single visual, the Snowflake, making it easy to evaluate Smoore International Holdings' overall financial health at a glance.

Looking For More Investment Ideas Beyond Smoore International Holdings?

If the Smoore International Holdings story has sharpened your thinking about buybacks, earnings power and regulatory risk, it can be useful to compare it with other businesses that share some of those traits. The Simply Wall St Screener lets you filter for specific financial profiles so you can line up a broader watchlist that matches your own criteria rather than relying on headlines.

• If you want potential mispricing plus solid fundamentals, scan a curated set of 199 high quality undervalued stocks that pair healthy balance sheets with cash flow support.
• If income is a key part of your plan, review a hand picked group of 225 dividend fortresses that focus on higher yields with an eye on stability.
• If capital preservation matters most, concentrate on a basket of 221 resilient stocks with low risk scores that screen for resilience and lower overall risk scores.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.